NO20030585L - Bruk av triazintrionsulfoner for a bekjempe koksidiose - Google Patents

Bruk av triazintrionsulfoner for a bekjempe koksidiose

Info

Publication number
NO20030585L
NO20030585L NO20030585A NO20030585A NO20030585L NO 20030585 L NO20030585 L NO 20030585L NO 20030585 A NO20030585 A NO 20030585A NO 20030585 A NO20030585 A NO 20030585A NO 20030585 L NO20030585 L NO 20030585L
Authority
NO
Norway
Prior art keywords
triazintrion
sulfones
coccidiosis
combat
combat coccidiosis
Prior art date
Application number
NO20030585A
Other languages
English (en)
Norwegian (no)
Other versions
NO20030585D0 (no
Inventor
Hans-Christian Mundt
Gisela Greif
Iris Bill
Original Assignee
Bayer Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bayer Ag filed Critical Bayer Ag
Publication of NO20030585L publication Critical patent/NO20030585L/no
Publication of NO20030585D0 publication Critical patent/NO20030585D0/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/53—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with three nitrogens as the only ring hetero atoms, e.g. chlorazanil, melamine
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D251/00—Heterocyclic compounds containing 1,3,5-triazine rings
    • C07D251/02—Heterocyclic compounds containing 1,3,5-triazine rings not condensed with other rings
    • C07D251/12—Heterocyclic compounds containing 1,3,5-triazine rings not condensed with other rings having three double bonds between ring members or between ring members and non-ring members
    • C07D251/26—Heterocyclic compounds containing 1,3,5-triazine rings not condensed with other rings having three double bonds between ring members or between ring members and non-ring members with only hetero atoms directly attached to ring carbon atoms
    • C07D251/30—Only oxygen atoms
    • C07D251/34—Cyanuric or isocyanuric esters
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents
    • A61P33/02—Antiprotozoals, e.g. for leishmaniasis, trichomoniasis, toxoplasmosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
  • Medicinal Preparation (AREA)
  • Plural Heterocyclic Compounds (AREA)
NO20030585A 2000-08-17 2003-02-06 Bruk av triazintrionsulfoner for å bekjempe koksidiose NO20030585D0 (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE10040174A DE10040174A1 (de) 2000-08-17 2000-08-17 Verwendung von Triazintrion-Sulfonen zur Bekämpfung von Coccidiosen
PCT/EP2001/009060 WO2002014288A1 (de) 2000-08-17 2001-08-06 Verwendung von triazintrion-sulfonen zur bekämpfung von coccidiosen

Publications (2)

Publication Number Publication Date
NO20030585L true NO20030585L (no) 2003-02-06
NO20030585D0 NO20030585D0 (no) 2003-02-06

Family

ID=7652719

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20030585A NO20030585D0 (no) 2000-08-17 2003-02-06 Bruk av triazintrionsulfoner for å bekjempe koksidiose

Country Status (23)

Country Link
US (1) US7915257B2 (ja)
EP (1) EP1311491A1 (ja)
JP (1) JP2004506624A (ja)
KR (1) KR100803078B1 (ja)
CN (3) CN1469868A (ja)
AR (1) AR030378A1 (ja)
AU (2) AU7852201A (ja)
BR (1) BR0113268A (ja)
CA (1) CA2419471C (ja)
CZ (1) CZ300020B6 (ja)
DE (1) DE10040174A1 (ja)
HR (1) HRP20030194A2 (ja)
HU (1) HUP0303701A3 (ja)
MX (1) MXPA03001429A (ja)
MY (1) MY136518A (ja)
NO (1) NO20030585D0 (ja)
NZ (1) NZ524200A (ja)
PL (1) PL359709A1 (ja)
SK (1) SK1652003A3 (ja)
TW (1) TW200819431A (ja)
WO (1) WO2002014288A1 (ja)
YU (1) YU11703A (ja)
ZA (1) ZA200301225B (ja)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE102004001558A1 (de) * 2004-01-10 2005-08-18 Bayer Healthcare Ag Arzneimittel zur topischen Applikation bei Tieren
DE102006038292A1 (de) * 2006-08-16 2008-02-21 Bayer Healthcare Ag Transdermale Anwendung von Triazinen zur Bekämpfung von Coccidien-Infektionen
DE102007025908A1 (de) * 2007-06-01 2008-12-04 Bayer Healthcare Ag Formulierungen enthaltend Triazinone und Eisen
SI22751A (sl) * 2008-04-03 2009-10-31 Krka, D.D., Novo Mesto Toltrazuril z izboljĺ animi lastnostmi za raztapljanje
DE102009012423A1 (de) 2009-03-10 2010-09-16 Bayer Animal Health Gmbh Zubereitung auf Ölbasis
EP2740470A1 (en) * 2012-12-07 2014-06-11 Ceva Sante Animale Treatment of Coccidiosis with intramuscular triazine composition
EP2740469A1 (en) * 2012-12-07 2014-06-11 Ceva Sante Animale New treatments with triazines
EP2740492A1 (en) 2012-12-07 2014-06-11 Ceva Sante Animale Triazine formulations with a second active ingredient and surfactant(s)
CN102973497A (zh) * 2012-12-13 2013-03-20 江苏恒丰强生物技术有限公司 一种托曲珠利溶液及其制备方法
BR112020017341A2 (pt) 2018-02-26 2020-12-15 AlzeCure Pharma AB Derivados de triazina para o tratamento de doenças relacionadas a neurotrofinas
EP3578181A1 (en) * 2018-06-05 2019-12-11 Bayer Animal Health GmbH Formulation for use in the simultaneous treatment of coccidial infections and iron deficiencies
GB201810668D0 (en) 2018-06-28 2018-08-15 Stiftelsen Alzecure New compounds

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2413722C3 (de) 1974-03-21 1982-04-08 Bayer Ag, 5090 Leverkusen Neue 1-(4-Phenoxy-phenyl)-1,3,5-triazin-Derivate, ein Verfahren zu ihrer Herstellung sowie ihre Anwendung als Arzneimittel
DE2414612A1 (de) 1974-03-26 1975-10-16 Bayer Ag 1-aryluracile, verfahren zu ihrer herstellung sowie ihre verwendung als arzneimittel
DE2532363A1 (de) 1975-07-19 1977-02-03 Bayer Ag Substituierte 2-phenyl-1,2,4- triazin-3,5(2h,4h)-dione, verfahren zu ihrer herstellung sowie ihre verwendung als arzneimittel
DE2718799A1 (de) 1977-04-27 1978-11-09 Bayer Ag 1-(4-phenoxy-phenyl)-1,3,5-triazin- derivate, verfahren zu ihrer herstellung sowie ihre verwendung als arzneimittel und wachstumsfoerderer
US4255231A (en) * 1979-06-13 1981-03-10 Congoleum Corporation Carpet etching
DE3314739A1 (de) * 1983-04-23 1984-10-25 Bayer Ag, 5090 Leverkusen 1-(4-(4-(fluoralkylmethylthio- oder -sulfinyl- oder -sulfonyl-)phenoxy) phenyl)-1,3,5-triazin-2,4,6(1h,3h,5h)-trione, verfahren zu ihrer herstellung und ihre verwendung als coccidiosemittel
US4837029A (en) * 1987-04-06 1989-06-06 Carolina Medical Products, Inc. Low foaming, aqueously homogenizable rifampin composition
US4808404A (en) * 1988-01-11 1989-02-28 A. H. Robins Company, Inc. Live vaccine for coccidiosis utilizing coccidial sporozoites
DE19824483A1 (de) 1998-06-02 1999-12-09 Bayer Ag Halbfeste wäßrige Zubereitungen für orale Applikation von Toltrazuril-Sulfon
MXPA01003542A (es) * 1998-10-08 2002-09-18 New Ace Res Company Composiciones y metodos nuevos para la prevencion y tratamiento de enfermedad causada por protozoarios.
BR9916417A (pt) * 1998-12-22 2001-11-06 Bayer Ag Compostos triazinaona para tratamento de doenças devidas à sarcosystis, neospora e toxoplasma
US6150361A (en) * 1998-12-22 2000-11-21 Bayer Corporation Triazineone compounds for treating diseases due to sarcosystis, neospora and toxoplasma

Also Published As

Publication number Publication date
HUP0303701A3 (en) 2006-01-30
KR20030017659A (ko) 2003-03-03
US20040013699A1 (en) 2004-01-22
US7915257B2 (en) 2011-03-29
HUP0303701A2 (hu) 2004-03-29
NZ524200A (en) 2005-02-25
MXPA03001429A (es) 2004-05-04
PL359709A1 (en) 2004-09-06
AU2001278522B9 (en) 2002-02-25
MY136518A (en) 2008-10-31
BR0113268A (pt) 2003-07-08
TW200819431A (en) 2008-05-01
CN1853635A (zh) 2006-11-01
ZA200301225B (en) 2004-02-16
NO20030585D0 (no) 2003-02-06
YU11703A (sh) 2006-01-16
WO2002014288A1 (de) 2002-02-21
CZ300020B6 (cs) 2009-01-14
EP1311491A1 (de) 2003-05-21
JP2004506624A (ja) 2004-03-04
KR100803078B1 (ko) 2008-02-18
SK1652003A3 (en) 2004-02-03
AU7852201A (en) 2002-02-25
DE10040174A1 (de) 2002-02-28
CA2419471C (en) 2009-10-13
HRP20030194A2 (en) 2005-10-31
CA2419471A1 (en) 2003-02-14
CN1469868A (zh) 2004-01-21
CN101361743A (zh) 2009-02-11
AR030378A1 (es) 2003-08-20
AU2001278522B2 (en) 2007-03-22

Similar Documents

Publication Publication Date Title
AR028567A1 (es) Nuevos derivados de fenil-propargileter
CY2004011I1 (el) Aσυμμετρη συνθεση της πρεγαβαλινης
AR028596A1 (es) Nuevos derivados de fenilglicina
ID30590A (id) Celana sekali pakai jenis-celana pendek
AR028253A1 (es) Inhibidores de la glucogeno fosforilasa
NO20025508L (no) Substituerte tioacetamider
ATE354360T1 (de) Amidoacetonitrile zur bekämpfung von endoparasiten
DE60201461D1 (de) Arbeitsgerät, dessen Benutzer hinterher läuft
ID30187A (id) Dongkrak jenis pantagraf
DE60143985D1 (de) Os
PT1250321E (pt) Composicao de gliburida
DK1270069T3 (da) Anvendelse af et afsvovlningsmiddel
IS6954A (is) Notkun á enantíómerískt hreinu essítalóprami
NO20030585L (no) Bruk av triazintrionsulfoner for a bekjempe koksidiose
AU2001285325A1 (en) Use of threo-methylphenidate compounds to enhance memory
ID29711A (id) Peralatan untuk mengadakan air-bersalin
PT1322592E (pt) Derivados substituidos de 1-aminobutan-3-ol
ATE362074T1 (de) Befestigen von schalenbauteilen an rohrleitungen
DE50103366D1 (de) Polare Acrylathaftklebemassen
SE0203779L (sv) Url-baserad åtkomst till Aspect Objects
NO20041066L (no) Hydroksyeikosensyre-analoger
DE60110606D1 (de) 16alpha-methyl oder ethyl substituierte oestrogene
AR028007A1 (es) Procedimiento para preparar eteres de oxima
ATE404252T1 (de) Hochwirksamer antitranspirantstift
SE0002190D0 (sv) Use of a composition

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application